Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
University of California, San Diego
SN BioScience
I-Mab Biopharma US Limited
UNC Lineberger Comprehensive Cancer Center
Kansas State University
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
Genentech, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Cyprus University of Technology
PureTech
Medical University of South Carolina
University of Michigan Rogel Cancer Center
Cyteir Therapeutics, Inc.
Jacobio Pharmaceuticals Co., Ltd.
Acepodia Biotech, Inc.
Washington University School of Medicine
Jacobio Pharmaceuticals Co., Ltd.
Queen Mary University of London
Xencor, Inc.
Cedars-Sinai Medical Center
Celldex Therapeutics
Buddhist Tzu Chi General Hospital
STCube, Inc.
Istituti Clinici Scientifici Maugeri SpA
Massachusetts General Hospital
Catalysis SL
CytomX Therapeutics
Dana-Farber Cancer Institute
Umeå University
Emory University
Klus Pharma Inc.
Mayo Clinic
Endocyte
Eastern Cooperative Oncology Group
Fate Therapeutics
Duke University
Prelude Therapeutics
Quadriga Biosciences, Inc.
Institut de Cancérologie de Lorraine
University of Louisville
Xencor, Inc.
Ludwig Institute for Cancer Research